BlackRock, Inc. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
4,927,750 8.300% |
-1,018,595 (-17.13%) |
Filing |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
5,946,345 10.300% |
-266,568 (-4.29%) |
Filing |
| 2023-04-06 09:29 am Purchase |
2023-03-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
6,212,913 10.900% |
725,733 (+13.23%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
5,487,180 9.700% |
1,153,278 (+26.61%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
4,333,902 8.700% |
834,898 (+23.86%) |
Filing |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Twist Bioscience Corporation TWST |
BlackRock Inc. BLK |
3,499,004 7.200% |
1,580,926 (+82.42%) |
Filing |